Industry-initiated research
The clinical research landscape is complex and fragmented, which hampers efficiency and delays multicenter studies. WCN has in-depth knowledge of its research centers, manages the organization-wide study portfolio, and serves as the central point of contact for sponsors. Through our central position and oversight, we contribute to simplifying the conduct of clinical research.
We reduce fragmentation and administrative burden by organizing clinical research more effectively and efficiently. For industry-initiated studies, we offer a centralized approach that relieves both our sponsors and research centers. This results in more predictable, faster, and more efficient clinical trials.
// Interested in collaborating? Contact us
Our approach
We have a solid infrastructure and leverage our proven expertise to successfully facilitate (international) studies.
Our approach includes:
- Proven expertise: A network of 49 qualified research centers with a strong track record of reliable performance. Our unique combination of clinical, scientific, and operational trialist expertise provides a solid foundation for the successful execution of every study.
- Centralized processes: Designed for reliability and predictability. Our centralized site identification process ensures selection of the most suitable research centers for your project, while centralized contract management promotes efficiency for all stakeholders and accelerates study start-up.
- Consistent and professional support: Our dedicated team offers personalized guidance through fixed points of contact, ensuring transparent and efficient collaboration. Every project within WCN is assigned to a dedicated Study Manager and a Study Director (a participating WCN investigator). With a clear focus on supporting recruitment and retention, this centralized coordination and expert support enables optimal study execution for both sponsors and participating WCN centers.
- Quality assurance and training: We provide network-wide Standard Operating Procedures (SOPs), ICH-GCP training, and a comprehensive educational program for our research centers, ensuring they contribute to clinical research in line with the highest quality standards.
- Sustainable partnerships: We aim to build long-term collaborations with pharmaceutical companies, CROs, and academic partners.
Type of studies
Our study portfolio consists of international, industry-initiated clinical trials that contribute to optimizing treatment guidelines, ultimately improving patient health. It includes a broad range of studies, from early phase I–II trials to large-scale phase III studies, covering the full cardiovascular spectrum.
Would you like to learn more about how WCN strengthens research?
Download the flowchart of our approach here.